Last reviewed · How we verify

NCT06923085: CerRad-UE

Upper Extremity Dysfunction in Patients With Cervical Radiculopathy

Completed Last updated 11 April 2025
What this trial tests

trial testing Observational Assessment Only in Cervical Radiculopathy in 58 participants. Completed in 22 April 2023.

Timeline
22 September 2021
Primary endpoint
22 April 2023
22 April 2023

Quick facts

Lead sponsorUniversity of Beykent
StatusCompleted
Study typeOBSERVATIONAL
Enrollment58
Start date22 September 2021
Primary completion22 April 2023
Estimated completion22 April 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

University of Beykent

Who can join

Adults 18 to 65, any sex, with Cervical Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine how cervical radiculopathy (a pinched nerve in the neck) affects function in both arms, not just the symptomatic side. The investigators will evaluate 42 patients with different cervical nerve root involvement (C4-5, C5-6, or C6-7) and compare them to 16 control subjects with non-specific neck pain. The assessments will measure muscle strength, sensory function, hand performance, pain levels, and psychological factors. These evaluations may contribute to the development of rehabilitation programs for cervical radiculopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervical Radiculopathy

Currently open trials in the same condition.

Other University of Beykent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06923085.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing